Japanese Transportation Stock News

As Asian markets navigate the complexities of geopolitical tensions and fluctuating commodity prices, investors are keenly observing opportunities for value amid broader market shifts. In this environment, identifying undervalued stocks that may be trading at significant discounts can provide a strategic advantage, especially when these stocks possess strong fundamentals and growth potential in sectors poised to benefit from easing tensions and stabilizing economic conditions.

With inflation pressures flaring up again through energy prices, bond yields staying sensitive to every macro headline, and consumer confidence under strain, dependable income has rarely looked more valuable. That is where the Dividend Fortresses screener comes in. It focuses on rare 5%+ dividend yield stocks that aim to pair generous payouts with staying power through market storms. In this article, you will see three of the strongest names from that universe, along with clear, plain-English...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Japan Exchange Group (TSE:8697) is back in focus after subsidiary JPX Market Innovation & Research and Japan Securities Finance agreed to jointly advance a common data platform for automating securities back-office processes. See our latest analysis for Japan Exchange Group. The stock’s latest share price of ¥1,948.5 comes after a 1-day share price return of 1.43% and a 7-day return of 3.29%. The 1-year total shareholder return of 34.26% and 3-year total shareholder return of 102.38% point to...

It's been a mediocre week for Tsuruha Holdings Inc. ( TSE:3391 ) shareholders, with the stock dropping 13% to JP¥2,178...

The investors in Rorze Corporation 's ( TSE:6323 ) will be rubbing their hands together with glee today, after the...

KOMEDA Holdings Co., Ltd. ( TSE:3543 ) last week reported its latest yearly results, which makes it a good time for...

It's been a good week for ABC-Mart,Inc. ( TSE:2670 ) shareholders, because the company has just released its latest...

Saizeriya Co.,Ltd. ( TSE:7581 ) defied analyst predictions to release its half-yearly results, which were ahead of...

World Co., Ltd.'s ( TSE:3612 ) robust recent earnings didn't do much to move the stock. We believe that shareholders...

Shareholders might have noticed that Aeon Co., Ltd. ( TSE:8267 ) filed its yearly result this time last week. The early...

TSI HoldingsLtd (TSE:3608) has wrapped up FY 2026 with fourth quarter revenue of ¥50.5b and basic EPS of ¥8.73, set against trailing twelve month revenue of ¥167.1b and EPS of ¥60.47 that frame the full year picture. The company has seen quarterly revenue range from ¥30.6b to ¥50.5b across FY 2026, with basic EPS moving between a loss of ¥10.02 and a high of ¥33.81 over the same stretch. This provides investors with a clearer view of how earnings have moved around the headline growth...

HOYA, listed as TSE:7741, is considering a stock split or other measures to reduce its investment unit. The company aims to make its shares more accessible to a broader range of investors. Plans have not yet been finalized, so the outcome and timing of any change remain undecided. HOYA operates across optics related fields, including eyeglass lenses, medical endoscopes and semiconductor related products, which ties it closely to healthcare and technology demand. In recent years, these areas...

Latest FY 2026 earnings snapshot Takeuchi Mfg (TSE:6432) has wrapped up FY 2026 with fourth quarter revenue of ¥52.5 billion and basic EPS of ¥103.85, capping a year in which trailing twelve month revenue reached ¥225.3 billion and EPS came in at ¥611.92 as earnings grew 8.3% over the last year. The company has seen revenue move from ¥213.2 billion to ¥225.3 billion on a trailing twelve month basis, while EPS tracked from ¥552.44 to ¥611.92, which gives a fuller sense of how the top line and...

Kawasaki Heavy Industries has completed a 1-for-5 stock split effective 8 April 2026, increasing the number of shares outstanding without changing overall shareholder value. This move reshapes the company’s share structure, potentially broadening retail participation and altering how investors think about liquidity and trading access. We’ll now examine how the 1-for-5 stock split may influence Kawasaki Heavy Industries’ investment narrative and long-term equity story. AI is about to change...

Renesas Electronics (TSE:6723) is in focus after confirming that its Intersil radiation hardened ICs are integrated into key avionics and safety subsystems on NASA’s recently launched Artemis II crewed lunar mission. See our latest analysis for Renesas Electronics. The Artemis II contract arrives at a time when momentum in Renesas Electronics’ shares has been picking up, with a 7 day share price return of 16.95% and a 1 year total shareholder return of 59.16% pointing to growing investor...

An activist investor has built a stake in Ajinomoto, which holds a monopoly on a material used in artificial intelligence infrastructure. The move introduces a new shareholder voice that could influence how the company manages its AI related business and broader capital allocation. Ajinomoto (TSE:2802), trading at ¥4,652.0, has attracted fresh attention after an activist investor took a position in the company. The stock has logged very large 5 year returns, alongside gains of 40.0% year to...

It's been a good week for PAL GROUP Holdings CO., LTD. ( TSE:2726 ) shareholders, because the company has just released...

ORIX Corporation USA has acquired a majority stake in Hilco Global. The deal is driving the launch of an expanded asset-based lending platform that combines ORIX capital with Hilco asset expertise. The new platform is intended to offer more flexible and custom financing solutions across multiple industries. For investors watching ORIX (TSE:8591), this move comes at a time when the share price stands at ¥4,879.0 and the stock has recorded a 221.2% return over 5 years. Recent performance has...

Astellas Pharma (TSE:4503) licensed a novel AAV capsid from Dyno Therapeutics, designed for targeted gene therapy delivery to skeletal muscle. This is the first capsid licensed under the Astellas and Dyno collaboration and Dyno's first licensed muscle targeting capsid. The agreement focuses on improving gene therapy delivery and manufacturing efficiency for Astellas's programs. Astellas Pharma, a global pharmaceutical company listed on TSE:4503, has been building out its gene therapy...

Investors may be wondering if Nomura Research Institute is trading at a fair price or if the market is missing something in the current share price. The stock last closed at ¥4,511, with returns of 2.2% over 7 days and 3.9% over 30 days, alongside a 25.1% decline year to date and a 12.9% decline over 1 year. The 3 year and 5 year returns stand at 47.0% and 42.4% respectively. These mixed returns have put fresh attention on what is driving sentiment around Nomura Research Institute and...

Nidec (TSE:6594) has announced significant executive role changes, including the promotion of Masayuki Minai to Senior Vice President. Minai's remit now extends across compliance, risk management, and culture transformation, with adjustments also made to R&D leadership roles. These shifts reshape oversight of key control functions and research priorities, with potential implications for how the group is run day to day. Nidec shares most recently traded at ¥2,248.0, with the stock up 7.0%...

In the midst of geopolitical tensions and fluctuating energy markets, global indices have experienced notable volatility, with major U.S. stock indexes posting gains amid hopes for de-escalation in the Middle East. As investors navigate these uncertain times, identifying undervalued stocks can be a strategic approach to potentially capitalize on market inefficiencies and position portfolios for long-term growth.

On 8 April 2026, Sumitomo Pharma Co., Ltd.’s board met to consider and approve the issuance of new shares and a secondary offering. This potential combination of fresh equity and existing shareholder sales could alter both ownership structure and per-share economics for current investors. Next, we’ll examine how this planned equity issuance and secondary offering could reshape Sumitomo Pharma’s existing investment narrative. Find 20 companies with promising cash flow potential yet trading...